+ All Categories
Home > Documents > Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl...

Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl...

Date post: 24-May-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
95
Hirokazu Abe, Japan Financial disclosure: No Tamer Aboushwareb, United States Financial disclosure: Yes Company: Allergan Plc. Type of Financial Relationship: Employee Received: Salary Other: Conflict with CME Presentation: Adrian Abramczyk, Poland Financial disclosure: No Yoram Abramov, Israel Financial disclosure: No Vivian Aguilar, United States Financial disclosure: No Joanne Karen Aguinaldo, Philippines Financial disclosure: No Wael Agur, United Kingdom Financial disclosure: Yes Company: SEP Pharma Type of Financial Relationship: Speaker Received: Honoraria Other: Conflict with CME Presentation: Company: Astellas Type of Financial Relationship: Advisory Committee Member Received: Consulting Fee Other: Conflict with CME Presentation: Bard Company: Type of Financial Relationship: Consultant Received: Honoraria Other: Conflict with CME Presentation: Company: Boston Scientific Type of Financial Relationship: Consultant Received: Travel Grant Other: Conflict with CME Presentation: Company: Type of Financial Relationship: Consultant Received: Travel Grant Other: Conflict with CME Presentation: Neomedic Company: Coloplast Type of Financial Relationship: Other Received: Other Other: Supply of products for cadaver workshops Conflict with CME Presentation:
Transcript
Page 1: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Hirokazu Abe, Japan Financial disclosure: No

Tamer Aboushwareb, United StatesFinancial disclosure: Yes

Company: Allergan Plc.Type of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Adrian Abramczyk, Poland Financial disclosure: No

Yoram Abramov, Israel Financial disclosure: No

Vivian Aguilar, United States Financial disclosure: No

Joanne Karen Aguinaldo, Philippines Financial disclosure: No

Wael Agur, United Kingdom Financial disclosure: Yes

Company: SEP PharmaType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: Bard

Company: ­Type of Financial Relationship: Consultant Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: Boston ScientificType of Financial Relationship: Consultant Received: Travel Grant Other: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Consultant Received: Travel Grant Other: ­Conflict with CME Presentation: Neomedic

Company: ColoplastType of Financial Relationship: Other Received: OtherOther: Supply of products for cadaver workshopsConflict with CME Presentation: ­

Page 2: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Thomas Aigmueller, Austria Financial disclosure: No

Danita Akingba, United States Financial disclosure: No

May Alarab, Canada Financial disclosure: No

Ira Dominique Alatraca­Malonzo, Philippines Financial disclosure: No

Maria Alcoba, Argentina Financial disclosure: No

Alas Alexandriah, United States Financial disclosure: No

Anoshia Ali, United Kingdom Financial disclosure: No

Bruce Allan, Canada Financial disclosure: Yes

Company: Viveve Inc. Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: Viveve Inc. Type of Financial Relationship: Speaker Received: Consulting FeeOther: ­Conflict with CME Presentation: Viveve Inc.

Company: ­Type of Financial Relationship: Scientific Medical Advisor Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Sandrine Alonso, France Financial disclosure: No

salwan Al­Salihi, Australia Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: OtherOther: payment for speaking at an education nightConflict with CME Presentation: ­

Company: Boston scientificType of Financial Relationship: Speaker Received: OtherOther: payment for education presentationConflict with CME Presentation: No

Page 3: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Julio Alvarez, Chile Financial disclosure: No

Matias Alvarez, Chile Financial disclosure: No

Almira Amin­Ong, Philippines Financial disclosure: No

Fakhryalsadat Anaraki, Iran, Islamic Republic of Financial disclosure: No

Colette Anderson, United Kingdom Financial disclosure: No

Vasanth Andrews, United Kingdom Financial disclosure: No

Manon Andriot, France Financial disclosure: No

Breffini Anglim, Ireland Financial disclosure: No

Danielle Antosh, United States Financial disclosure: No

Kuri Aoki, Japan Financial disclosure: No

Inna Apolikhina, Russian Federation Financial disclosure: No

George Araklitis, United Kingdom Financial disclosure: Yes

Company: Astellas Pharma LtdType of Financial Relationship: Other Received: Travel Grant Other: Travel Grant to attend conferences and deliver talk for company Conflict with CME Presentation: ­

Camila Araujo, Brazil Financial disclosure: No

Marco Arellano, Chile Financial disclosure: No

Louise Arenholt, Denmark Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: Honoraria

Page 4: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Other: ­Conflict with CME Presentation: ­

Walter Artibani, Italy Financial disclosure: Yes

Company: Johnson & JohnsonType of Financial Relationship: Scientific Medical Advisor Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: IpsenType of Financial Relationship: Scientific Medical Advisor Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Angamuthu Arunkalaivanan, Australia Financial disclosure: No

Victoria Asfour, United Kingdom Financial disclosure: No

christophe assenmacher, Belgium Financial disclosure: No

Chutimon Asumpinwong, Thailand Financial disclosure: No

Kathiane Augusto, Brazil Financial disclosure: No

Ron Auslender, Israel Financial disclosure: No

Marcio Averbeck, Brazil Financial disclosure: Yes

Company: MedtronicType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: ColoplastType of Financial Relationship: Board Member Received: Consulting FeeOther: ­Conflict with CME Presentation: GSK

Company: ­Type of Financial Relationship: Other Received: SalaryOther: Internal ExpertConflict with CME Presentation: ­

TOLGA AYDIN, Turkey Financial disclosure: No

Page 5: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Azami Azinar, Indonesia Financial disclosure: No

Naiel Azzam, Israel Financial disclosure: No

Fiona Bach, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Other Received: Travel Grant Other: Travel and accommodation costs to attend conference and teaching course. Conflict with CME Presentation: ­

Fiona Bach, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Other Received: Travel Grant Other: Travel and accommodation costs to conference and teaching Conflict with CME Presentation: ­

Thorsten Bach, Germany Financial disclosure: No

Jean­Pierre Baeyens, Belgium Financial disclosure: No

reza bagherzadeh saba, Iran, Islamic Republic of Financial disclosure: No

Alexandra Bain, Canada Financial disclosure: No

Aswini Balachandran, United Kingdom Financial disclosure: No

Paul Ballard, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Emma Baltazar, Mexico Financial disclosure: No

Matteo Balzarro, Italy Financial disclosure: No

Edmund Baracat, Brazil Financial disclosure: No

Page 6: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Wlodzimierz Baranowski, Poland Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: Travel Grant Other: ­Conflict with CME Presentation: ­

Company: AMSType of Financial Relationship: Scientific Medical Advisor Received: Consulting FeeOther: ­Conflict with CME Presentation: Promedon

Company: ­Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

jorge barbabosa, Mexico Financial disclosure: No

Matthew Barber, United States Financial disclosure: Yes

Company: UptoDateType of Financial Relationship: Other Received: RoyaltyOther: For on­line chaptersConflict with CME Presentation: ­

Company: ElsevierType of Financial Relationship: Other Received: RoyaltyOther: for book Hysterectomy for Benign DiseaseConflict with CME Presentation: No

Marco Barbieri, Brazil Financial disclosure: No

Angelica Barbosa, Brazil Financial disclosure: No

Angelica Barbosa, Brazil Financial disclosure: No

Hayley Barnes, United States Financial disclosure: No

Tomer Bar­Noy, Israel Financial disclosure: No

Gyorgy Bartfai, Hungary Financial disclosure: Yes

Company: Lyra Type of Financial Relationship: Other Received: Grant/Research SupportOther: participation in contracted research protocol No: CD­14­005rev00Conflict with CME Presentation: ­

Page 7: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Silvia Bassi, Italy Financial disclosure: No

Maya Basu, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Lucy Bates, Australia Financial disclosure: No

Nancy Baxter, Canada Financial disclosure: No

tony bazi, Lebanon Financial disclosure: No

Oscar Becerra, Chile Financial disclosure: No

Fanny BECHARD, France Financial disclosure: No

Carlos Beltran, Colombia Financial disclosure: No

Masha Ben Zvi, Israel Financial disclosure: No

jan benijts, Belgium Financial disclosure: No

Sophie Bennenbroek, Netherlands Financial disclosure: No

Christopher Benness, Australia Financial disclosure: No

Jonathan Berkowitz, Canada Financial disclosure: No

Blumel Bernardita, Chile Financial disclosure: No

Marie­Eve Berube, Canada Financial disclosure: No

Page 8: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Heloisa Bettiol, Brazil Financial disclosure: No

Kheira Bettir, United States Financial disclosure: No

Karine Bezerra, Brazil Financial disclosure: No

Pallab Bhattacharyya, United States Financial disclosure: No

Ana Maria Bianchi­Ferraro, Brazil Financial disclosure: No

Jan Bienkiewicz, Poland Financial disclosure: No

Przemyslaw Bienkowski, Poland Financial disclosure: Yes

Company: AdamedType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: Medical ExpertsType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Angelini

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: Polfa Tarchomin Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Elli Lilly

Suzanne Biers, United Kingdom Financial disclosure: No

Andreisa Bilhar, Brazil Financial disclosure: No

colin birch, Canada Financial disclosure: No

Page 9: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Vesna Bjelic­Radisic, Austria Financial disclosure: No

Jonna Bjoerk, Denmark Financial disclosure: No

MIJA BLAGANJE, Slovenia Financial disclosure: No

Jerry Blaivas, United States Financial disclosure: Yes

Company: SymptelligenceType of Financial Relationship: Board Member Received: Intellectual Property RightsOther: ­Conflict with CME Presentation: ­

Jozsef Bodis, Hungary Financial disclosure: No

barbara bodner­adler, Austria Financial disclosure: No

Marilia Bonacin, Canada Financial disclosure: No

Maria Bortolini, Brazil Financial disclosure: No

Anton Bosman, Netherlands Financial disclosure: No

Carolyn Botros, United States Financial disclosure: No

Sylvia Botros, United States Financial disclosure: Yes

Company: Boston ScientificType of Financial Relationship: Other Received: Grant/Research SupportOther: investigator for surgical research trialConflict with CME Presentation: ­

Geronimo Augusto Bourguignon, Argentina Financial disclosure: No

Savanna Boutin, Canada Financial disclosure: No

chiara bovo, Italy Financial disclosure: No

Page 10: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Nicola Boyd, New Zealand Financial disclosure: No

Hernan Braun, Chile Financial disclosure: No

Meirav Braverman, Israel Financial disclosure: No

Alejandra Bravo­Balado, Colombia Financial disclosure: No

Rhiannon Bray, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Other Received: Travel Grant Other: Support to attend a training courseConflict with CME Presentation: ­

Suzanne Breeman, United Kingdom Financial disclosure: No

Henk Bremer, Netherlands Financial disclosure: No

Erin Brennand, Canada Financial disclosure: Yes

Company: Boston ScientificType of Financial Relationship: Other Received: Grant/Research SupportOther: Investigator Initiated, Industry Supported Research GrantConflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

ALINE BRILHANTE, Brazil Financial disclosure: No

Luiz Gustavo Brito, Brazil Financial disclosure: No

Bernadette Brown, Australia Financial disclosure: No

Heidi Brown, United States Financial disclosure: Yes

Company: Grand Rounds, Inc.Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Page 11: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: Pelvalon, IncType of Financial Relationship: Other Received: Grant/Research SupportOther: I am the principal investigator for the University of Wisconsin's involvement in a multicenter clinical trial funded by Pelvalon, Inc. I do notreceive any monetary compensation for my participation in this research.Conflict with CME Presentation: AAGL (American Association of Gynecologic Laparoscopists)

Company: ­Type of Financial Relationship: Speaker Received: Travel Grant Other: Travel to teach course at AAGL annual meeting was reimbursed by AAGL Conflict with CME Presentation: ­

Molly Brown, United States Financial disclosure: Yes

Linda Brubaker, United States Financial disclosure: Yes

Company: Female Pelvic Medicine and Reconstructive Surgery (AUGS)Type of Financial Relationship: Other Received: OtherOther: StipendConflict with CME Presentation: ­

Company: Up to DateType of Financial Relationship: Other Received: OtherOther: stipendConflict with CME Presentation: ­

Esther Bruehlmann, Switzerland Financial disclosure: No

S Bulchandani, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Other Received: Travel Grant Other: Travel expenses and conference fees Conflict with CME Presentation: ­

suvit bunyavejchevin, Thailand Financial disclosure: No

Fleur Burden, United Kingdom Financial disclosure: No

Divan Burger, South Africa Financial disclosure: No

Alberto Bustos, Chile Financial disclosure: No

Lorenzo Bustos Bustos, Chile Financial disclosure: No

IGOR BUT, Slovenia Financial disclosure: Yes

Page 12: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: ASTELLASType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

JURE BUT, Slovenia Financial disclosure: No

Kelly Buzatti, Brazil Financial disclosure: No

Pamela Cacho, Argentina Financial disclosure: No

Felipe Caetano, Brazil Financial disclosure: No

Juan Caicedo, Colombia Financial disclosure: No

Geertje Callewaert, Belgium Financial disclosure: No

Carlomer Camanong, Australia Financial disclosure: No

Manriquez Camilo, Chile Financial disclosure: No

Patrick Campbell, United Kingdom Financial disclosure: No

nicole canario, Chile Financial disclosure: No

Arielle Cantor, Canada Financial disclosure: No

tingting cao, China Financial disclosure: No

Linda Cardozo, United Kingdom Financial disclosure: Yes

Company: AllerganType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: AMSType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: Astellas

Page 13: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: ­Type of Financial Relationship: Board Member Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: PfizerType of Financial Relationship: Scientific Medical Advisor Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: BMR

Company: Pierre­FabreType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Marcus Carey, Australia Financial disclosure: Yes

Company: Gynaecologic Pty LtdType of Financial Relationship: Stock Shareholder Received: OtherOther: no monies distributedConflict with CME Presentation: ­

Kevin Carlson, Canada Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Advisory Committee Member Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Scientific Medical Advisor Received: Consulting FeeOther: ­Conflict with CME Presentation: Pfizer

Company: ­Type of Financial Relationship: Advisory Committee Member Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: PfizerType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Lesley Carr, Canada Financial disclosure: Yes

Company: Cook MyositeType of Financial Relationship: Other Received: Grant/Research SupportOther: Research SupportConflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Advisory Committee Member Received: Honoraria

Page 14: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Other: ­Conflict with CME Presentation: Ferring

Company: ­Type of Financial Relationship: Advisory Committee Member Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: PfizerType of Financial Relationship: Speaker's Bureau Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Advisory Committee Member Received: HonorariaOther: ­Conflict with CME Presentation: Allergan

Melissa Carroll, United States Financial disclosure: No

Rufus Cartwright, United Kingdom Financial disclosure: No

Rufus Cartwright, United Kingdom Financial disclosure: No

Catherine Casanova Demmler, Chile Financial disclosure: No

Juan Castaëo, Colombia Financial disclosure: No

CHRISTEL CASTELLI, France Financial disclosure: No

Peter Castillo, United States Financial disclosure: Yes

Company: Boston ScientificType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: ScitonType of Financial Relationship: Speaker's Bureau Received: HonorariaOther: ­Conflict with CME Presentation: Cogentix

Company: ­Type of Financial Relationship: Speaker's Bureau Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: Analytics MedicalType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Page 15: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Henry Castro, Chile Financial disclosure: No

Juan Cataîo, Colombia Financial disclosure: No

Jessica Caudwell­Hall, Australia Financial disclosure: No

Geraldo Cavalcanti, Brazil Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Ricardo Cavalli, United States Financial disclosure: No

Karen Ceballos, Chile Financial disclosure: No

Maria Angela Cerruto, Italy Financial disclosure: No

Mauro Cervigni, Italy Financial disclosure: No

E CETINDAG AYDIN, Turkey Financial disclosure: No

Susan Chamberlain, Canada Financial disclosure: No

Michelle Chan, Canada Financial disclosure: No

SYMPHOROSA SHING CHEE CHAN, Hong Kong Financial disclosure: No

Michael Chancellor, United States Financial disclosure: Yes

Company: Cook MyositeType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Neeraja Chandrasekaran, United States Financial disclosure: No

Page 16: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Cheng­Tao Chang, United States Financial disclosure: No

chiapei chang, Taiwan Financial disclosure: No

Yu Wei Chang, Taiwan Financial disclosure: No

Yue Chang, China Financial disclosure: No

Christopher Chapple, United Kingdom Financial disclosure: Yes

Company: AllerganType of Financial Relationship: Other Received: OtherOther: Scientific Study/Trial (Researcher/Author), Meeting Participant/Lecturer, Consultant/Advisor Conflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Other Received: OtherOther: Grant, Scientific Study/Trial (Researcher/Author), Meeting Participant/Lecturer, Consultant/Advisor Conflict with CME Presentation: Boston Scientific

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: Meeting Participant/LecturerConflict with CME Presentation: ­

Company: MedtronicType of Financial Relationship: Consultant Received: Consulting FeeOther: Consultant/AdvisorConflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Other Received: OtherOther: Scientific Study/Trial (Researcher/Author), Consultant/Advisor Conflict with CME Presentation: Recordati

G.D. CHEN, Taiwan Financial disclosure: No

Gin­Den Chen, Taiwan Financial disclosure: No

Yisong Chen, China Financial disclosure: No

Zhuoran Chen, Australia Financial disclosure: No

Rachel Yau Kar CHEUNG, Hong Kong Financial disclosure: No

Page 17: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Kato Chikako, Japan Financial disclosure: No

Hui Chin, United Kingdom Financial disclosure: No

Padraic Chisholm, United States Financial disclosure: No

Seung Joo Chon, Korea, Republic of Financial disclosure: No

Nurul Choudhury, United Kingdom Financial disclosure: Yes

Company: Astellas Pharma europe LtdType of Financial Relationship: Employee Received: SalaryOther: Full time employee (medical department)Conflict with CME Presentation: ­

Theresa Chow, Canada Financial disclosure: No

Corina Christmann, Switzerland Financial disclosure: No

Mayne Christopher, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Sandy Chua, Philippines Financial disclosure: No

Kao Chuan Chi, Taiwan Financial disclosure: No

novera chughtai, Pakistan Financial disclosure: No

Christopher Chung, United States Financial disclosure: No

Doreen Chung, United States Financial disclosure: No

Diane Cinco, Philippines Financial disclosure: No

Page 18: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Veronica Ciolfi, Canada Financial disclosure: Yes

Company: Laborie Medical Technologies Type of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Aisling Clancy, Canada Financial disclosure: No

kevin cline, United States Financial disclosure: No

Louise Cloney, United Kingdom Financial disclosure: No

Suelene Coelho, Brazil Financial disclosure: No

Kevin Connors, United States Financial disclosure: Yes

Company: Solace TherapueticsType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Kevin Cooper, United Kingdom Financial disclosure: No

Elizabeth Copeland, United Kingdom Financial disclosure: No

James Corden, United KingdomFinancial disclosure: Yes

Company: SwabTech Ltd Type of Financial Relationship: Founder Received: SalaryOther: ­Conflict with CME Presentation: ­

Paolo Corsi, Italy Financial disclosure: No

Edna Cortes, Mexico Financial disclosure: No

peter coyte, Canada Financial disclosure: Yes

Company: Harper Grey LLPType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Page 19: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Wladimir Cruces Duran, Chile Financial disclosure: No

Maria Cruz, Brazil Financial disclosure: No

Boris Cuevas Villegas, Chile Financial disclosure: No

Geoffrey Cundiff, Canada Financial disclosure: No

Geoffrey CundiffDONOT USE, Canada Financial disclosure: No

Marina Cunha, Belgium Financial disclosure: No

natasha curtiss, United Kingdom Financial disclosure: No

Catriona Czyrnyj, Canada Financial disclosure: No

Nathan Dalalo, United States Financial disclosure: No

Justin Daly, Australia Financial disclosure: No

Christina Dancz, United States Financial disclosure: No

Patricia Dankers, Netherlands Financial disclosure: No

Ruchika Darapaneni, United States Financial disclosure: No

Shimon Dascalu, Israel Financial disclosure: No

joanna davies, United Kingdom Financial disclosure: No

G. Willy Davila, United States Financial disclosure: Yes

Company: AllerganType of Financial Relationship: Consultant Received: Consulting Fee

Page 20: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Other: ­Conflict with CME Presentation: ­

Company: A­CellType of Financial Relationship: Other Received: Grant/Research SupportOther: Multicenter trial participantConflict with CME Presentation: Cogentix

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: Alma LasersType of Financial Relationship: Other Received: Grant/Research SupportOther: Investigator­initiated research grantConflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Other Received: Grant/Research SupportOther: Investigator­initiated research grantConflict with CME Presentation: Pfizer

Company: ColoplastType of Financial Relationship: Other Received: Grant/Research SupportOther: Multicenter trial participantConflict with CME Presentation: ­

Ashraf Dawood, Saudi Arabia Financial disclosure: No

edilson de castro, Brazil Financial disclosure: No

albert de decker, Belgium Financial disclosure: No

Jan de Leeuw, Netherlands Financial disclosure: No

Lore De Meutter, Netherlands Financial disclosure: No

Renaud de Tayrac, France Financial disclosure: Yes

Company: Boston ScientificType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: ColoplastType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Stefan De Wachter, Belgium Financial disclosure: Yes

Page 21: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: MedtronicType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Allergan

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Arnaud Decatoire, France Financial disclosure: No

Emily Deegan, Canada Financial disclosure: No

John DeLancey, United States Financial disclosure: Yes

Company: Proctor and GambleType of Financial Relationship: Other Received: OtherOther: University of Michigan receives partial salary support for research.Conflict with CME Presentation: ­

Company: HologicType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

THANH DELLINGER, United States Financial disclosure: No

Jan Deprest, Belgium Financial disclosure: Yes

Company: MedriType of Financial Relationship: Other Received: Grant/Research SupportOther: Unconditional grant; company is not designer of the study, owner or results or have any say in publication of results. Conflict with CME Presentation: ­

Company: EthiconType of Financial Relationship: Other Received: HonorariaOther: Demonstration operations (side by side teaching)Conflict with CME Presentation: Fotona

Company: ­Type of Financial Relationship: Other Received: Grant/Research SupportOther: Unconditional grant; company is not designer of the study, owner or results or have any say in publication of results. Conflict with CME Presentation: ­

Company: ColoplastType of Financial Relationship: Other Received: Grant/Research SupportOther: Framework 7 programme of the European Commission for novel material developmentConflict with CME Presentation: ­

Page 22: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: ­Type of Financial Relationship: Other Received: Grant/Research SupportOther: Unconditional grant; company is not designer of the study, owner or results or have any say in publication of results. Conflict with CME Presentation: Blasingame & Garard Law

Company: Ethicon EndosurgeryType of Financial Relationship: Other Received: Grant/Research SupportOther: Support for an investigator initiated study on long term follow up of sacropexy ­ unconditional: industry has no input in design andreporting and is not owner of the data.Conflict with CME Presentation: Clayton Law

Company: ­Type of Financial Relationship: Other Received: HonorariaOther: Expert witnessConflict with CME Presentation: ­

Marion DESGRANGES, France Financial disclosure: No

David Desseauve, France Financial disclosure: No

Hemikaa Devakumar, United States Financial disclosure: No

bruno deval, France Financial disclosure: No

Carlos Diaz, Colombia Financial disclosure: No

Laura Didomizio, Canada Financial disclosure: No

Hans Peter Dietz, Australia Financial disclosure: No

alex digesu, United Kingdom Financial disclosure: No

luisa diniz, Brazil Financial disclosure: No

mucio diniz, Brazil Financial disclosure: No

Suskhan Djusad, Indonesia Financial disclosure: No

Roger Dmochowski, United States Financial disclosure: Yes

Company: allerganType of Financial Relationship: Consultant Received: Consulting Fee

Page 23: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Other: ­Conflict with CME Presentation: ­

Company: MedtronicType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Rebecca Do, United States Financial disclosure: No

Simony do Nascimento, Brazil Financial disclosure: No

F DOKMECI, Turkey Financial disclosure: No

Renata dos Santos, Brazil Financial disclosure: No

Harold Drutz, Canada Financial disclosure: No

Anupreet Dua, United Kingdom Financial disclosure: No

Jonathan Duckett, United Kingdom Financial disclosure: Yes

Company: American Medical systemsType of Financial Relationship: Scientific Medical Advisor Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Company: Boston scientificType of Financial Relationship: Scientific Medical Advisor Received: Grant/Research SupportOther: ­Conflict with CME Presentation: Astellas

Company: ­Type of Financial Relationship: Scientific Medical Advisor Received: OtherOther: Commercial research fundingConflict with CME Presentation: ­

Omar Duenas, United States Financial disclosure: No

olivier dumay, France Financial disclosure: No

Chantal Dumoulin, Canada Financial disclosure: No

Sonia Dutta, United States Financial disclosure: No

Page 24: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Peter Dwyer, Australia Financial disclosure: No

Abeer Eddib, United States Financial disclosure: No

Vladimir Egorov, United States Financial disclosure: Yes

Company: Advanced Tactile Imaging, Inc. Type of Financial Relationship: Stock Shareholder Received: OtherOther: Nothing received. I invested into this company. Conflict with CME Presentation: ­

Company: Advanced Tactile Imaging, Inc. Type of Financial Relationship: CEO Received: SalaryOther: ­Conflict with CME Presentation: Artann Laboratories, Inc.

Company: ­Type of Financial Relationship: Employee Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Patric Eichelberger, Switzerland Financial disclosure: No

Regina El Dib, Brazil Financial disclosure: No

Andrew Elders, United Kingdom Financial disclosure: Yes

Company: Glasgow Caledonian UniversityType of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Dina El­Hamamsy, United Kingdom Financial disclosure: No

Mohamed Elhodaiby, United Kingdom Financial disclosure: No

Susanne Elsner, Germany Financial disclosure: No

Chelsea Elwood, Canada Financial disclosure: No

Doyo Enki, United Kingdom Financial disclosure: No

Page 25: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Tsvia Erlich, Israel Financial disclosure: Yes

Company: ConTIPI Medical Ltd.Type of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Guy Eslick, Australia Financial disclosure: No

Luis Espaillat­Rijo, United States Financial disclosure: No

Ivo Faehnle, Switzerland Financial disclosure: No

Ken Fan, United States Financial disclosure: No

Bilal Farhan, United States Financial disclosure: No

Balint Farkas, Hungary Financial disclosure: Yes

Company: Hungarian Academy of SciencesType of Financial Relationship: Consultant Received: SalaryOther: ­Conflict with CME Presentation: ­

Nelli Farkas, Hungary Financial disclosure: No

Abdalla Fayyad, United Kingdom Financial disclosure: No

Abdalla Fayyad, United Kingdom Financial disclosure: No

Ido Feferkorn, Israel Financial disclosure: No

SABRINE. FEITOZA, Brazil Financial disclosure: No

Zoltan Fekete, Hungary Financial disclosure: No

Antonio Fernandes, Portugal Financial disclosure: No

Page 26: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Gustavo Fernandes, Brazil Financial disclosure: No

HERVE FERNANDEZ, France Financial disclosure: No

Ruwan Fernando, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Cristine Ferreira, Brazil Financial disclosure: No

Philippe Ferry, France Financial disclosure: Yes

Company: Porges­ColoplastType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Jaroslav Feyereisl, Czech Republic Financial disclosure: No

ELYONARA FIGUEIREDO, Brazil Financial disclosure: No

Carolina Figueroa, Chile Financial disclosure: No

Bach Fiona, United Kingdom Financial disclosure: No

Myra FITZPATRICK, Ireland Financial disclosure: No

Tricia Fleming, United States Financial disclosure: No

Cathy Flood, Canada Financial disclosure: No

Robinson Flores, Chile Financial disclosure: No

Camilo Fonseca, Argentina Financial disclosure: No

Page 27: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

ABIGAIL FORD, United Kingdom Financial disclosure: No

Tahereh Forooghifar, Iran, Islamic Republic of Financial disclosure: No

Marc­Antoine Fournier, Canada Financial disclosure: No

Laetitia FRADET, France Financial disclosure: No

Tamires Franca, Brazil Financial disclosure: No

Malcolm Frazer, Australia Financial disclosure: No

Robert Freeman, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: travel expensesConflict with CME Presentation: ­

Company: PfizerType of Financial Relationship: Speaker Received: HonorariaOther: travel expensesConflict with CME Presentation: Medinvent

Company: ­Type of Financial Relationship: Other Received: OtherOther: Travel expense for attending a meeting organized by Medinvent; no honoraria received Conflict with CME Presentation: ­

Company: co­inventor of the Episcissors­60Type of Financial Relationship: Other Received: OtherOther: IP rights and inventor feesConflict with CME Presentation: ­

Talia Friedman, Australia Financial disclosure: No

Xavier Fritel, France Financial disclosure: No

Akiko Fujisaki, Japan Financial disclosure: No

Konrad Futyma, Poland Financial disclosure: Yes

Company: ASTELLASType of Financial Relationship: Speaker Received: Honoraria

Page 28: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Other: ­Conflict with CME Presentation: ­

Lukasz Futyma, Poland Financial disclosure: No

Lukasz Futyma, Poland Financial disclosure: No

BERTRAND GACHON, France Financial disclosure: No

Adam Gafni­Kane, United States Financial disclosure: No

Louise­Helene Gagnon, Canada Financial disclosure: No

Petra Gal, Hungary Financial disclosure: No

Marie Gantz, United States Financial disclosure: Yes

Company: Boston ScientificType of Financial Relationship: Other Received: Grant/Research SupportOther: PIConflict with CME Presentation: ­

Company: MedspiraType of Financial Relationship: Other Received: OtherOther: Device used for research purposes purchased by the Pelvic Floor Disorder Network (PFDN) Data Coordinating Center on behalf of thePFDN at a reduced cost in return for consultation by PFDN investigators on device development.Conflict with CME Presentation: ­

Alaina Garbens, Canada Financial disclosure: No

Bobby Garcia, United States Financial disclosure: No

Adrian Gaspar, Argentina Financial disclosure: Yes

Company: FotonaType of Financial Relationship: Speaker Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Adrian GasparDONOTUSE, Argentina Financial disclosure: Yes

Company: FotonaType of Financial Relationship: Consultant Received: Travel Grant Other: ­Conflict with CME Presentation: ­

Page 29: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Hans Geelen, Netherlands Financial disclosure: No

Gelman Gelman, United Kingdom Financial disclosure: No

Wolf Gelman, United Kingdom Financial disclosure: No

BARBARA CRISTINA GENTILE, Italy Financial disclosure: No

Roxana Geoffrion, Canada Financial disclosure: Yes

Company: Boston ScientificType of Financial Relationship: Other Received: HonorariaOther: Preceptor/proctor of surgical colleagues for use of Capio device and midurethral slings (Obtryx)Conflict with CME Presentation: ­

Company: DuchesnayType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Zinat Ghanbari, Iran, Islamic Republic of Financial disclosure: No

Gamal Ghoniem, United States Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: CogentixType of Financial Relationship: Other Received: Grant/Research SupportOther: research grantConflict with CME Presentation: ­

Ilias Giarenis, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Other Received: Travel Grant Other: Travel expenses Conflict with CME Presentation: ­

Jennifer Giel, United States Financial disclosure: Yes

Page 30: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: xType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Vivian Gies, United States Financial disclosure: No

Bradley Gill, United States Financial disclosure: Yes

Company: Medscape / WebMD Type of Financial Relationship: Other Received: HonorariaOther: Honoraria for Authoring ArticlesConflict with CME Presentation: ­

Kiren Gill, United Kingdom Financial disclosure: No

Shimon Ginath, Israel Financial disclosure: No

David Ginsberg, United States Financial disclosure: Yes

Company: AllerganType of Financial Relationship: Consultant Received: Consulting FeeOther: Data safety boardConflict with CME Presentation: ­

Company: AllerganType of Financial Relationship: Other Received: Grant/Research SupportOther: InvestigatorConflict with CME Presentation: ­

Manoel Girao, Brazil Financial disclosure: No

Karin Glavind, Denmark Financial disclosure: No

Marianne Glavind­Kristensen, Denmark Financial disclosure: No

Cathryn Glazener, United Kingdom Financial disclosure: No

Dobrochna Globerman, Canada Financial disclosure: No

Dominik Godlewski, Poland Financial disclosure: No

Page 31: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Anna Goebel, United States Financial disclosure: No

Ondrej Gojis, Czech Republic Financial disclosure: No

Roger Goldberg, United States Financial disclosure: Yes

Company: Boston ScientificType of Financial Relationship: Consultant Received: RoyaltyOther: Consultant, and Intellectual Property / RoyaltyConflict with CME Presentation: ­

Corrie Goldfinger, Canada Financial disclosure: No

howard goldman, United States Financial disclosure: Yes

Company: AxonicsType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: MedtronicType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: Allergan

Company: ­Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: NuvectraType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Other Received: OtherOther: Study SupportConflict with CME Presentation: Medtronic

Eyal Goldschmidt, Israel Financial disclosure: No

TIAGO GOMES, Brazil Financial disclosure: No

Margarita Gomez Chavarin, Mexico Financial disclosure: No

EMILCY GONCALVES, Brazil Financial disclosure: No

Page 32: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

DOMINGO GONZALEZ MENDOZA, Mexico Financial disclosure: No

Katherine Gooch, United States Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Employee Received: SalaryOther: I am not presenting the abstract.Conflict with CME Presentation: ­

Elena Gorbunova, Russian Federation Financial disclosure: No

Felicity Gould, Australia Financial disclosure: Yes

Company: Cambridge Medical RoboticsType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Andy Grant, United Kingdom Financial disclosure: No

Matthieu Gratton, Canada Financial disclosure: No

Thomas Gray, United Kingdom Financial disclosure: No

Lonny Green, United States Financial disclosure: No

Joy Greer, United States Financial disclosure: No

Georgios Grigoriadis, United Kingdom Financial disclosure: No

Robert Grill, Czech Republic Financial disclosure: Yes

Company: inVentiv Health Care Type of Financial Relationship: Other Received: HonorariaOther: Believe study performingConflict with CME Presentation: ­

Cara Grimes, United States Financial disclosure: No

Anique Grob, Netherlands Financial disclosure: No

Page 33: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Klara Grohregin, Czech Republic Financial disclosure: No

Jennifer Gruenenfelder, United States Financial disclosure: Yes

Company: Allergan plcType of Financial Relationship: Other Received: OtherOther: InvestigatorConflict with CME Presentation: ­

Magdalena Grzybowska, Poland Financial disclosure: Yes

Company: Astellas Pharma Sp. z o.o.Type of Financial Relationship: Other Received: OtherOther: Participation fee for ICS Annual MeetingConflict with CME Presentation: ­

Company: Astellas Pharma Sp. z o.o.Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Julia Guenther­Borstel, Germany Financial disclosure: No

Nathan Guerette, United States Financial disclosure: Yes

Company: ScitonType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: Boston ScientificType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Nibedita gupta, United Kingdom Financial disclosure: No

Shashank Gurjar, United Kingdom Financial disclosure: No

jorge Haddad, Brazil Financial disclosure: Yes

Company: Apsen FarmaceuticaType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: Astellas PharmaType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: Boston Scientific Company

Page 34: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: PromedonType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

SUZANNE HAGEN, United Kingdom Financial disclosure: No

Michael Halaska, Czech Republic Financial disclosure: No

Douglass Hale, United States Financial disclosure: Yes

Company: AllerganType of Financial Relationship: Other Received: Grant/Research SupportOther: InvestigatorConflict with CME Presentation: ­

Company: Up to DateType of Financial Relationship: Other Received: RoyaltyOther: ReviewerConflict with CME Presentation: AUGS

Company: ­Type of Financial Relationship: Board Member Received: Travel Grant Other: ­Conflict with CME Presentation: ­

Petra Hall Viborg, Denmark Financial disclosure: No

How Han, Singapore Financial disclosure: No

Ji­Yeon Han, Korea, Republic of Financial disclosure: No

Rebecca Hancock­Howard, Canada Financial disclosure: Yes

Company: GoogleType of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Company: GoogleType of Financial Relationship: Employee Received: OtherOther: StockConflict with CME Presentation: Amaris

Company: ­Type of Financial Relationship: Employee Received: Salary

Page 35: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Other: ­Conflict with CME Presentation: ­

Victoria Handa, United States Financial disclosure: Yes

Company: Up to DateType of Financial Relationship: Other Received: RoyaltyOther: Chapter authorConflict with CME Presentation: ­

Tomas Hanus, Czech Republic Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: JanssenType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Coloplast

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Engelbert Hanzal, Austria Financial disclosure: Yes

Company: Astellas, AllerganType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: Johnson & Johnson Gynecare, Astellas, Pfizer, Kwizda, Allergan Type of Financial Relationship: Speaker Received: Travel Grant Other: ­Conflict with CME Presentation: Pfizer, Kwizda

Company: ­Type of Financial Relationship: Speaker Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

rhonda harris, United Kingdom Financial disclosure: No

Anna Harrison, United States Financial disclosure: No

Hashim Hashim, United Kingdom Financial disclosure: No

Linda Havelkova, Czech Republic Financial disclosure: No

Page 36: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Nir Haya, Israel Financial disclosure: No

Haojie He, China Financial disclosure: No

Aparna Hegde, India Financial disclosure: No

Christine Hemming, United Kingdom Financial disclosure: No

Pattaya Hengrasmee, Thailand Financial disclosure: No

Etienne Henn, South Africa Financial disclosure: No

Etienne Henn, South Africa Financial disclosure: No

Marcelino Hernandez, Mexico Financial disclosure: No

Sender Herschorn, Canada Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Advisory Committee Member Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Other Received: Grant/Research SupportOther: InvestigatorConflict with CME Presentation: Allergan

Company: ­Type of Financial Relationship: Advisory Committee Member Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: AllerganType of Financial Relationship: Other Received: Grant/Research SupportOther: InvestigatorConflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Advisory Committee Member Received: HonorariaOther: ­Conflict with CME Presentation: Pfizer

Company: IpsenType of Financial Relationship: Advisory Committee Member Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Page 37: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Duane Hickling, Canada Financial disclosure: Yes

Company: AllerganType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: PfizerType of Financial Relationship: Advisory Committee Member Received: HonorariaOther: ­Conflict with CME Presentation: No

Janet Hill, Canada Financial disclosure: No

Simon Hill, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: RoyaltyOther: ­Conflict with CME Presentation: ­

Company: Specialty European PharmaType of Financial Relationship: Speaker Received: Travel Grant Other: ­Conflict with CME Presentation: No

Zahava Hirsch, United States Financial disclosure: No

Susanne Hólbfer, Austria Financial disclosure: No

Anna Hóllein, Austria Financial disclosure: No

Lukas Horcicka, Czech Republic Financial disclosure: Yes

Company: ApogephaType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: SCA

Company: ­Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: Hartmann RicoType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Page 38: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: ­Type of Financial Relationship: ­ Received: ­Other: ­Conflict with CME Presentation: Yes

Shigeo Horie, Japan Financial disclosure: No

Christine Horton, United States Financial disclosure: No

Kaori Hoshino, Japan Financial disclosure: No

KAY HOSKEY, United States Financial disclosure: No

Sara Houlihan, Canada Financial disclosure: No

Susanne Housmans, Belgium Financial disclosure: No

david howard, United States Financial disclosure: No

Mette Terp Hoybye, Denmark Financial disclosure: Yes

Company: AbbvieType of Financial Relationship: Speaker Received: SalaryOther: ­Conflict with CME Presentation: ­

Wu­Chiao Hsieh, Taiwan Financial disclosure: No

Chun Hsu, Taiwan Financial disclosure: No

Changdong Hu, China Financial disclosure: No

Keqin Hua, China Financial disclosure: No

Kuan­Hui Huang, Taiwan Financial disclosure: No

Moses Huang, United Kingdom Financial disclosure: Yes

Page 39: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: Astellas Pharma EuropeType of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Ting­Wen Huang, Japan Financial disclosure: No

Wen­Chen Huang, Taiwan Financial disclosure: No

Petr Hubka, Czech Republic Financial disclosure: No

Tanja Huelder, Switzerland Financial disclosure: No

Man­Jung Hung, Taiwan Financial disclosure: No

Jo Hunter, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Other Received: OtherOther: Sponsored to attend EUGA and IUGA 2016/2017 e.g. Flights/accommodation costs paid.Conflict with CME Presentation: ­

Eric Hurtado, United States Financial disclosure: Yes

Company: Cook MyositeType of Financial Relationship: Other Received: Grant/Research SupportOther: Funds for participating in clinical trial to departmentConflict with CME Presentation: ­

Company: Alma LaserType of Financial Relationship: Other Received: Grant/Research SupportOther: Funds for participating in clinical trial to departmentConflict with CME Presentation: Acell Matristem

Company: ­Type of Financial Relationship: Other Received: Grant/Research SupportOther: Funds for participating in clinical trial to departmentConflict with CME Presentation: ­

Company: ColoplastType of Financial Relationship: Other Received: Grant/Research SupportOther: Funds for participating in clinical trial to departmentConflict with CME Presentation: ­

Company: ­Type of Financial Relationship: ­ Received: ­Other: ­Conflict with CME Presentation: Yes

Page 40: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Karen Ruben Husby, Denmark Financial disclosure: No

Heinrich Husslein, Austria Financial disclosure: No

Momoe Hyakutake, Canada Financial disclosure: No

Lucie Hympanova, Belgium Financial disclosure: Yes

Company: European Commission in the FP7­framework (Bip­Upy; NMP3­LA­2012­310389)Type of Financial Relationship: Advisory Committee Member Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Ludek Hyncik, Czech Republic Financial disclosure: No

Rami Ibrahim, Jordan Financial disclosure: No

masao ichikawa, Japan Financial disclosure: No

Joanna IntHout, Netherlands Financial disclosure: No

Sharif Ismail, United Kingdom Financial disclosure: No

Aya Itani, Lebanon Financial disclosure: No

Shilpa Iyer, United States Financial disclosure: No

Karny Jacoby, United States Financial disclosure: Yes

Company: SolaceType of Financial Relationship: Other Received: Grant/Research SupportOther: Principal Investigator and consultantConflict with CME Presentation: ­

Company: AllerganType of Financial Relationship: Other Received: Grant/Research SupportOther: researchConflict with CME Presentation: Astellas

Company: ­Type of Financial Relationship: Other Received: Grant/Research SupportOther: researchConflict with CME Presentation: ­

Page 41: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Mohammad Jaffal, Lebanon Financial disclosure: No

Rajeshree Jain, India Financial disclosure: No

Rodrigo Jales, Brazil Financial disclosure: No

Tomezsko Janet, United States Financial disclosure: No

Alexandra Jankowski, United States Financial disclosure: Yes

Company: St Jude MedicalType of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Ron Jankowski, United States Financial disclosure: Yes

Company: Cook MyoSite Inc.Type of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

SANDRA JARAMILLO, Colombia Financial disclosure: No

Zsuzsanna Jarmy­Di Bella, Brazil Financial disclosure: No

Marjorie Jean­Michel, United States Financial disclosure: No

Helen Jefferis, United Kingdom Financial disclosure: No

John Jelovsek, United States Financial disclosure: Yes

Company: NICHD Pelvic Floor Disorders NetworkType of Financial Relationship: Other Received: SalaryOther: NIH salary supportConflict with CME Presentation: ­

Company: UpToDate Type of Financial Relationship: Other Received: RoyaltyOther: Author royaltiesConflict with CME Presentation: No

Page 42: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Hee Jong Jeong, Korea, Republic of Financial disclosure: No

Swati Jha, United Kingdom Financial disclosure: No

Hege Johannessen, Norway Financial disclosure: No

Danielle Johansen, United States Financial disclosure: No

Shawna Johnston, Canada Financial disclosure: Yes

Company: Pfizer CanadaType of Financial Relationship: Advisory Committee Member Received: HonorariaOther: ­Conflict with CME Presentation: ­

KS Joseph, Canada Financial disclosure: No

Martina Juergensen, Germany Financial disclosure: No

Cassia Juliato, Brazil Financial disclosure: No

Zuzana Kachlirova, Czech Republic Financial disclosure: No

Nelle Kaljouw, Netherlands Financial disclosure: No

Susan Kalota, United States Financial disclosure: Yes

Company: AllerganType of Financial Relationship: Other Received: Grant/Research SupportOther: Participant in Clinical trialsConflict with CME Presentation: ­

Company: CogentixType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Astellas

Company: ­Type of Financial Relationship: Other Received: Grant/Research SupportOther: Participant in Clinical trialsConflict with CME Presentation: ­

Page 43: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Pawel Kaminski, Poland Financial disclosure: Yes

Company: Gedeon RichterType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

naheed kapadia, United Arab EmiratesFinancial disclosure: No

FRANCISCO KAPLAN, Chile Financial disclosure: No

Shveta Kapoor, Australia Financial disclosure: No

Vishal Kapoor, Australia Financial disclosure: No

Emmanuel Karantanis, Australia Financial disclosure: No

Sara Karbage, Brazil Financial disclosure: No

Debjyoti Karmakar, Australia Financial disclosure: No

Kazunori Kasama, Japan Financial disclosure: Yes

Company: EthiconType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: MedtronicType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Yes

chikako kato, Japan Financial disclosure: No

Melissa Kaufman, United States Financial disclosure: Yes

Company: Cook Myosite, IncType of Financial Relationship: Other Received: OtherOther: Global Principle Investigator for Phase III clinical trialConflict with CME Presentation: ­

Company: Boston Scientific, IncType of Financial Relationship: Other Received: Honoraria

Page 44: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Other: Resident cadaver course instructorConflict with CME Presentation: Yes

Hervinder Kaur, Australia Financial disclosure: No

Alex Kavanagh, Canada Financial disclosure: No

Erin Kelly, Canada Financial disclosure: No

Ulrik Kesmodel, Denmark Financial disclosure: Yes

Company: MSDType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Ahmed Khalil, United Kingdom Financial disclosure: No

Hisham Khalil, Canada Financial disclosure: No

Mohammed Khan, Qatar Financial disclosure: No

Yasmine Khayyami, Denmark Financial disclosure: No

Vikram Khullar, United Kingdom Financial disclosure: No

Aethele Khunda, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: European specialty pharmaType of Financial Relationship: Other Received: Travel Grant Other: got sponsored to attend a scientific meeting (travel and accommodation)Conflict with CME Presentation: No

Mark Kibschull, Canada Financial disclosure: No

Jacqueline Kikuchi, United States Financial disclosure: No

Page 45: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Charles Kilpatrick, United States Financial disclosure: Yes

Company: UpToDate Type of Financial Relationship: Consultant Received: Consulting FeeOther: chapter fee providedConflict with CME Presentation: ­

Company: American Board of Obstetrics and GynecologyType of Financial Relationship: Other Received: Consulting FeeOther: Oral Board Examiner, travel expenses paid for Conflict with CME Presentation: American Urogynecology Society

Company: ­Type of Financial Relationship: Board Member Received: OtherOther: travel expenses paid forConflict with CME Presentation: ­

Company: American College of Obstetrics and GynecologyType of Financial Relationship: Consultant Received: OtherOther: travel expenses paid forConflict with CME Presentation: ­

Company: ­Type of Financial Relationship: ­ Received: ­Other: ­Conflict with CME Presentation: No

Chang Hee Kim, Korea, Republic of Financial disclosure: No

Myung Ki Kim, Korea, Republic of Financial disclosure: No

Shunaha Kim­Fine, Canada Financial disclosure: No

Shunaha Kim­Fine, Canada Financial disclosure: No

Manami Kinjo, Japan Financial disclosure: No

takeya kitta, Japan Financial disclosure: No

Niels Klarskov, Denmark Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: SalaryOther: ­Conflict with CME Presentation: ­

Stangel­Wojcikiewicz Klaudia, Poland Financial disclosure: No

Page 46: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

wenche klerkx, Netherlands Financial disclosure: No

Tomasz Kluz, Poland Financial disclosure: No

Emily Kobernik, United States Financial disclosure: No

Marianne Koch, Austria Financial disclosure: No

Jacek Kociszewski, Germany Financial disclosure: No

Heinz Koelbl, Austria Financial disclosure: No

Nicole Koenig, Canada Financial disclosure: No

Wei Koh, Singapore Financial disclosure: No

Tine Kopp, Denmark Financial disclosure: No

Marcela Kotoulova, Czech Republic Financial disclosure: No

Sabrina Kousgaard, Denmark Financial disclosure: No

Michal Krcmar, Czech Republic Financial disclosure: No

Jan Krhut, Czech Republic Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Ladislav Krofta, Czech Republic Financial disclosure: No

Caecilie Krogsgaard Tolstrup, Denmark Financial disclosure: No

Page 47: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Louise Krska, United Kingdom Financial disclosure: No

Jennifer Kruger, New Zealand Financial disclosure: No

Petrus Kruger, South Africa Financial disclosure: No

Michael Krychman, United States Financial disclosure: Yes

Company: NERI and Evidera.Type of Financial Relationship: Consultant Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Company: Shionogi Inc, Pfizer, Palatin, Therapeutics MD, Viveve Medical, Materna, Applied Biology, Sermonix, and SproutPharmaceuticals.Valeant Pharmaceutics Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: Shionogi and Valeant Pharmaceuticals

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Magda Krzycka, Poland Financial disclosure: No

Halpern Ksenia, Austria Financial disclosure: No

Lorenz Kuessel, Austria Financial disclosure: No

Annette Kuhn, Switzerland Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: AllerganType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: No

Patricia Kultgen, United States Financial disclosure: Yes

Company: Cook Research IncorporatedType of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Page 48: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Anthony Kupelian, United Kingdom Financial disclosure: Yes

Company: Olympus MedicalType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Zhu Lan, China Financial disclosure: No

felicia lane, United States Financial disclosure: No

dirk lange, Canada Financial disclosure: Yes

Company: Boston ScientificType of Financial Relationship: Consultant Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Company: Cook MedicalType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: Bard Medical

Company: ­Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: AdvaTec Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: Urotech GmbH

Lucia Lara, Brazil Financial disclosure: No

Olivia Lara, United States Financial disclosure: No

Maryse Larouche, Canada Financial disclosure: No

Thomas Larsen, Denmark Financial disclosure: No

Rosa Maria Laterza, Austria Financial disclosure: No

Page 49: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Thomas Laura, United Kingdom Financial disclosure: No

Darren Lazare, Canada Financial disclosure: Yes

Company: Boston ScientificType of Financial Relationship: Other Received: Grant/Research SupportOther: Boston Scientific has provided research funding for a clinical trial.Conflict with CME Presentation: ­

Hyo Serk Lee, Korea, Republic of Financial disclosure: No

Joseph Lee, Australia Financial disclosure: Yes

Company: AMSType of Financial Relationship: Other Received: Grant/Research SupportOther: ethics approved research GrantConflict with CME Presentation: ­

Company: BSCIType of Financial Relationship: Other Received: Grant/Research SupportOther: ethics approved research GrantConflict with CME Presentation: Yes

LAI LOI LEE, Hong Kong Financial disclosure: No

Patricia Lee, Canada Financial disclosure: No

Seong Ho Lee, Korea, Republic of Financial disclosure: No

Pichai Leerasiri, Thailand Financial disclosure: No

Alison Leitch, Australia Financial disclosure: No

Hermann Leitner, Austria Financial disclosure: No

Monika Leitner, Switzerland Financial disclosure: No

Nucelio Lemos, Canada Financial disclosure: Yes

Company: MedtronicType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Page 50: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: MedtronicType of Financial Relationship: Speaker Received: Travel Grant Other: ­Conflict with CME Presentation: Medtronic

Company: ­Type of Financial Relationship: Other Received: Grant/Research SupportOther: Researcher Initiated ResearchConflict with CME Presentation: ­

Company: LaborieType of Financial Relationship: Other Received: Grant/Research SupportOther: Researcher Initiated ResearchConflict with CME Presentation: ­

Company: ­Type of Financial Relationship: ­ Received: ­Other: ­Conflict with CME Presentation: No

Gil Levy, Israel Financial disclosure: Yes

Company: Medtronic Inc.Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: Lyra Medical Ltd. Type of Financial Relationship: Stock Shareholder Received: Ownership InterestOther: ­Conflict with CME Presentation: Yes

Adrienne Li, Canada Financial disclosure: No

Weiguang Li, United Kingdom Financial disclosure: No

yunyuan li, Canada Financial disclosure: No

Ching­Chung Liang, Taiwan Financial disclosure: No

Xianghua Liang, China Financial disclosure: No

Nicolas Lidgett, Argentina Financial disclosure: No

Yik Lim, Australia Financial disclosure: No

Clara Lima, Brazil Financial disclosure: No

Page 51: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Harvard Lin, Singapore Financial disclosure: No

Teng­Lung Lin, Taiwan Financial disclosure: No

Yi­Hao Lin, Taiwan Financial disclosure: No

Anna Sofie Lindquist, Denmark Financial disclosure: No

Gerold Link, Netherlands Financial disclosure: No

Ryan Joseph Lirazan, Philippines Financial disclosure: No

zhang lishi, United States Financial disclosure: No

Sarka Lisonkova, Canada Financial disclosure: No

Rogier Litjens, Netherlands Financial disclosure: No

Linda Liu, Costa Rica Financial disclosure: No

Mamie Liu, United Kingdom Financial disclosure: No

Tsia­Shu Lo, Taiwan Financial disclosure: No

Jennifer Locke, Canada Financial disclosure: No

Jemina Loganathan, United Kingdom Financial disclosure: No

Cheng Long, Taiwan Financial disclosure: No

Emma Long, United Kingdom Financial disclosure: No

Page 52: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Emilio Longo, Argentina Financial disclosure: No

Gunnar Lose, Denmark Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Scientific Medical Advisor Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Company: ConturaType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: No

Thais Lourenco, Brazil Financial disclosure: No

Danny Lovatsis, Canada Financial disclosure: No

Catherine Lovatt, Canada Financial disclosure: No

Plamen Lozano, Austria Financial disclosure: No

Svjetlana Lozo, United States Financial disclosure: No

YONGXIAN LU, China Financial disclosure: No

Suellen Lucena, Brazil Financial disclosure: No

Vincent Lucente, United States Financial disclosure: Yes

Company: AllerganType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: ACELLType of Financial Relationship: Other Received: Grant/Research SupportOther: ResearchConflict with CME Presentation: Coloplast

Company: ­Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: ColoplastType of Financial Relationship: Speaker

Page 53: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Shionogi

Company: Advances Tactile Imaging Type of Financial Relationship: Other Received: Grant/Research SupportOther: RsearchConflict with CME Presentation: ­

ADOLF LUKANOVIC, Slovenia Financial disclosure: No

daniela luna seguel, Chile Financial disclosure: No

Aiming LV, China Financial disclosure: No

AAB Lycklama a Nijeholt, Netherlands Financial disclosure: No

Guus Lycklama a Nijeholt, Netherlands Financial disclosure: No

Stephen Lye, Canada Financial disclosure: No

Graeme MacLennan, United Kingdom Financial disclosure: No

Andrew Macnab, Canada Financial disclosure: No

Sheila Macneil, United KingdomFinancial disclosure: No

Chendrimada Madhu, United Kingdom Financial disclosure: No

Thais Magalhaes, Brazil Financial disclosure: No

Pedro Magnani, Brazil Financial disclosure: No

Christopher Maher, Australia Financial disclosure: No

Page 54: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Jane Mahoney, United States Financial disclosure: No

Barbara Maier, Austria Financial disclosure: No

Ewelina Malanowska, Poland Financial disclosure: No

Stephanie Malczewski, United StatesFinancial disclosure: No

Shazia Malik, United States Financial disclosure: No

Jittima Manonai, Thailand Financial disclosure: No

MARCOS MARANGONI, Brazil Financial disclosure: No

Milena Marcolino, Brazil Financial disclosure: No

Naama Marcus­Braun, Israel Financial disclosure: Yes

Company: Lyra Medical Ltd. Type of Financial Relationship: Other Received: Grant/Research SupportOther: Participating in sponsored studyConflict with CME Presentation: ­

Janet Marin, Mexico Financial disclosure: No

Gabriela Marini, Brazil Financial disclosure: No

Renato Marques, Brazil Financial disclosure: No

Julian Marschalek, Austria Financial disclosure: No

Marie­Louise Marschalek, Austria Financial disclosure: No

Alois Martan, Czech Republic Financial disclosure: Yes

Company: AstelasType of Financial Relationship: Consultant Received: Consulting Fee

Page 55: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Other: ­Conflict with CME Presentation: ­

Company: MeditradeType of Financial Relationship: Other Received: HonorariaOther: PreceptorConflict with CME Presentation: No

Laura Martin, United States Financial disclosure: No

Maria Laura Martinez, Argentina Financial disclosure: No

Pedro Martins, Portugal Financial disclosure: No

Jaromir Masata, Czech Republic Financial disclosure: No

Leticia Matoso, Brazil Financial disclosure: No

Priscila Matsuoka, Brazil Financial disclosure: No

Katerina Maxova, Czech Republic Financial disclosure: No

Alarab May, Canada Financial disclosure: No

Joseph May, Israel Financial disclosure: No

Kurt McCammon, United States Financial disclosure: Yes

Company: AllerganType of Financial Relationship: Other Received: Grant/Research SupportOther: ResearchConflict with CME Presentation: ­

Company: AMSType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Solace

Company: ­Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: SolaceType of Financial Relationship: Other Received: Grant/Research SupportOther: ResearchConflict with CME Presentation: ­

Page 56: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: ­Type of Financial Relationship: ­ Received: ­Other: ­Conflict with CME Presentation: Yes

Colleen McDermott, Canada Financial disclosure: No

Alison McDonald, United Kingdom Financial disclosure: No

Cynthia McKinney, United States Financial disclosure: No

Tim McKinney, United States Financial disclosure: Yes

Company: Laborie Medical Co.Type of Financial Relationship: Consultant Received: SalaryOther: ­Conflict with CME Presentation: ­

Linda McLean, Canada Financial disclosure: Yes

Company: Natural Sciences and Engineering Council of CanadaType of Financial Relationship: Other Received: Grant/Research SupportOther: Research operating funds awarded through peer­reviewed competition.Conflict with CME Presentation: ­

Company: University of OttawaType of Financial Relationship: Other Received: Grant/Research SupportOther: Research operating funds awarded through peer­reviewed competition.Conflict with CME Presentation: Physiotherapy Foundation of Canada

Company: ­Type of Financial Relationship: Other Received: Grant/Research SupportOther: Research operating funds awarded through peer­reviewed competition.Conflict with CME Presentation: ­

Company: Chiaro EnterprisesType of Financial Relationship: Other Received: Grant/Research SupportOther: Contract research was completed.Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: ­ Received: ­Other: ­Conflict with CME Presentation: No

susan meikle, United States Financial disclosure: No

Mariana Meinberg, Brazil Financial disclosure: No

Page 57: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Joan Melendez Munoz, Australia Financial disclosure: No

Elizabeth Meller, United States Financial disclosure: No

NADIA MELO, Brazil Financial disclosure: No

Jerome Melon, Australia Financial disclosure: No

Shawn Menefee, United States Financial disclosure: Yes

Company: UpToDate Type of Financial Relationship: Other Received: RoyaltyOther: Chapter on prophylactic use of vault suspension at time of hysterectomyConflict with CME Presentation: ­

Riry Meria, Indonesia Financial disclosure: No

TRISTAN MES, Netherlands Financial disclosure: No

Alfredo Milani, Netherlands Financial disclosure: No

Kelsey Mills, Canada Financial disclosure: Yes

Company: Speaker's Bureau ­ BayerType of Financial Relationship: Speaker's Bureau Received: HonorariaOther: ­Conflict with CME Presentation: ­

M Mina, India Financial disclosure: No

Pawel Miotla, Poland Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Other Received: HonorariaOther: subinvestigator in clinical trialConflict with CME Presentation: Allergan

Company: ­Type of Financial Relationship: Other Received: Honoraria

Page 58: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Other: subinvestigator in clinical trialConflict with CME Presentation: ­

Company: BayerType of Financial Relationship: Other Received: HonorariaOther: subinvestigator in clinical trialConflict with CME Presentation: ­

Company: ­Type of Financial Relationship: ­ Received: ­Other: ­Conflict with CME Presentation: Yes

Elaheh Miri Ashtiani, Iran, Islamic Republic of Financial disclosure: No

MASAYUKI MITSUI, Japan Financial disclosure: Yes

Company: Panasonic CorporationType of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Goran Mitulovic, Austria Financial disclosure: No

Fernandi Moegni, Indonesia Financial disclosure: No

Murielle MOLLO, France Financial disclosure: No

robert molnar, Israel Financial disclosure: No

Deborah Money, Canada Financial disclosure: Yes

Company: MerckType of Financial Relationship: Other Received: Grant/Research SupportOther: Merck funds vaccine studies i conduct as an investigator ­Conflict with CME Presentation: ­

Company: GskType of Financial Relationship: Other Received: Grant/Research SupportOther: Gsk funds vaccine studies that i conduct as an investigatorConflict with CME Presentation: No

John Money­Taylor, United Kingdom Financial disclosure: No

MARILENE MONTEIRO, Brazil Financial disclosure: No

Page 59: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

valeria montuoso, Argentina Financial disclosure: No

Kate Moore, Australia Financial disclosure: No

Maria del Rocio Morales Gomez, Mexico Financial disclosure: No

Shingo Moriyama, Japan Financial disclosure: No

Rafael Moroni, Brazil Financial disclosure: No

Helene Moser, Switzerland Financial disclosure: No

Nicolas MOTTET, France Financial disclosure: No

Verinsa Mouajou, Canada Financial disclosure: No

Blanca Munoz, Mexico Financial disclosure: No

Blanca Muñoz, Mexico Financial disclosure: No

Giulia Muraca, Canada Financial disclosure: No

Francis Muriithi, United Kingdom Financial disclosure: No

Miles Murphy, United States Financial disclosure: Yes

Company: Ethicon Women's Health & Urology Type of Financial Relationship: Other Received: OtherOther: Expert Legal WitnessConflict with CME Presentation: ­

Company: Boston ScientificType of Financial Relationship: Other Received: Grant/Research SupportOther: Research site for FDA­ordered 522 study of UpholdConflict with CME Presentation: No

Christine Murray, Australia Financial disclosure: No

Page 60: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Yong Gil Na, Korea, Republic ofFinancial disclosure: No

Koichi Nagao, Japan Financial disclosure: No

Koichi Nakajima, Japan Financial disclosure: No

Tosho Nakano, Japan Financial disclosure: Yes

Company: Panasonic CorporationType of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Lahari Nandikanti, United States Financial disclosure: No

maria napoli, Argentina Financial disclosure: No

John Navas, United States Financial disclosure: No

Hedwig Neels, Belgium Financial disclosure: No

Chandrasekaran Neeraja, United States Financial disclosure: No

Zoltan Nemeth, Austria Financial disclosure: No

Xochitl Netzahualcoyotzi, Mexico Financial disclosure: No

Susie Newton, United States Financial disclosure: No

Kai Lyn Ng, Singapore Financial disclosure: No

Roy Ng, Singapore Financial disclosure: No

soo­cheen Ng, Taiwan Financial disclosure: No

Page 61: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Zheng Yuan Ng, Singapore Financial disclosure: No

Danh Nguyen, United States Financial disclosure: No

Nobel Nguyen, United States Financial disclosure: No

Tina Nguyen, Canada Financial disclosure: No

Jonathan Nicholls, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: PfizerType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: No

Mark Nigro, Canada Financial disclosure: No

Victor Nitti, United States Financial disclosure: Yes

Company: AllerganType of Financial Relationship: Other Received: Grant/Research SupportOther: Incestigator Clinical Trial Conflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Other Received: Grant/Research SupportOther: Investigator Clinical Trial Conflict with CME Presentation: Serenity

Company: ­Type of Financial Relationship: Stock Shareholder Received: Ownership InterestOther: ­Conflict with CME Presentation: ­

Company: Cook MyocyteType of Financial Relationship: Other Received: Grant/Research SupportOther: Investigator clinical trialConflict with CME Presentation: ­

Company: ­Type of Financial Relationship: ­ Received: ­Other: ­Conflict with CME Presentation: Yes

Ke Niu, China Financial disclosure: No

Page 62: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Antonio Nogueira, Brazil Financial disclosure: No

Jimmy nomura, Japan Financial disclosure: No

yasuhisa nomura, Japan Financial disclosure: No

Stig Norderval, Norway Financial disclosure: No

Antoine Nordez, France Financial disclosure: No

John Norrie, United Kingdom Financial disclosure: No

Peggy Norton, United States Financial disclosure: No

Lukasz Nowakowski, Poland Financial disclosure: No

Kikuo Nutahara, Japan Financial disclosure: Yes

Company: Otsuka PharmaceuticalType of Financial Relationship: Scientific Medical Advisor Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Company: Daiichi Sankyo Co.Type of Financial Relationship: Scientific Medical Advisor Received: Grant/Research SupportOther: ­Conflict with CME Presentation: No

Lucy Nye, United States Financial disclosure: No

Willi Oberaigner, Austria Financial disclosure: No

Aneta Obloza, United Kingdom Financial disclosure: No

Amy O'Boyle, United States Financial disclosure: No

Colm O'Boyle, Ireland Financial disclosure: No

Page 63: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Mizuho Okawa, Japan Financial disclosure: No

Bobby O'Leary, Ireland Financial disclosure: No

Alicja Olejnik, Poland Financial disclosure: No

Sallie Oliphant, United States Financial disclosure: No

Pedro Oliveira, Portugal Financial disclosure: No

dumay olivier, France Financial disclosure: No

Adedamola Onifade, United Kingdom Financial disclosure: No

Barry O'Reilly, IrelandFinancial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: PfizerType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: No

Amelia Orejudos, United States Financial disclosure: Yes

Company: Allergan plcType of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Francisco Orejuela, United StatesFinancial disclosure: No

Monica Oria, Brazil Financial disclosure: No

Catriona O'Sullivan, Ireland Financial disclosure: No

Orfhlaith O'Sullivan, Ireland Financial disclosure: Yes

Page 64: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: PfizerType of Financial Relationship: Other Received: HonorariaOther: Honoraria to attend a medical conferenceConflict with CME Presentation: ­

Company: AllerganType of Financial Relationship: Other Received: OtherOther: Subsidised to attend a training courseConflict with CME Presentation: No

lin li ow, Australia Financial disclosure: No

Begum Ozel, United States Financial disclosure: No

Anna Padoa, Israel Financial disclosure: No

Maria Chiara Paganotto, United Kingdom Financial disclosure: No

Avita Pahwa, United States Financial disclosure: No

Cristina Palmer, United States Financial disclosure: No

isabel palmer, United KingdomFinancial disclosure: No

hunshan pan, Taiwan Financial disclosure: No

Ivilina Pandeva, United Kingdom Financial disclosure: No

Jessica Papillon­Smith, Canada Financial disclosure: No

John Pardey, Australia Financial disclosure: No

Isabella Parente Ribeiro Frota, Brazil Financial disclosure: No

Elliya Park, Canada Financial disclosure: No

Jong Mok Park, Korea, Republic of Financial disclosure: No

Page 65: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Victoria Parker, United Kingdom Financial disclosure: No

Gustavo Parra, Colombia Financial disclosure: No

gustavo adolfo parra solano, Colombia Financial disclosure: No

Ana Pascoal, United Kingdom Financial disclosure: No

Alejandro Pattillo, Chile Financial disclosure: No

Lucila Pavan, Argentina Financial disclosure: No

Michal Pazdrak, Poland Financial disclosure: No

Annacecilia Peacher­Seaney, United States Financial disclosure: No

Jasmine Pedroso, United States Financial disclosure: No

Jolene Peh, Singapore Financial disclosure: No

Rob Pelger, Netherlands Financial disclosure: Yes

Company: AMGENType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: AstraZenecaType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Novartis

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Wei­Xia Peng, Japan Financial disclosure: No

Glaucia Pereira, Brazil Financial disclosure: No

Page 66: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

rafael perez, Argentina Financial disclosure: No

ALIN PETCHAROPAS, Thailand Financial disclosure: No

Kenneth Peters, United States Financial disclosure: Yes

Company: Medtronic, Inc.Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: StimGuard, Inc.Type of Financial Relationship: Consultant Received: Ownership InterestOther: ­Conflict with CME Presentation: Allergan, Inc.

Company: ­Type of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Tatiana Pfiffer, Germany Financial disclosure: No

Minh­Duy Phan, Australia Financial disclosure: No

Justyna Piaskowska­Cala, Poland Financial disclosure: No

Fernanda Piculo, Brazil Financial disclosure: No

lespinasse pierre, United States Financial disclosure: No

Ágatha Pires, Brazil Financial disclosure: No

Maria Pisano, Argentina Financial disclosure: No

Sarah Pixton, Australia Financial disclosure: No

Javier Pizarro­Berdichevsky, United States Financial disclosure: No

Manuel Plata, Colombia Financial disclosure: No

Page 67: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Mauricio Plata, Colombia Financial disclosure: Yes

Company: PfizerType of Financial Relationship: Speaker Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Company: NeomedicType of Financial Relationship: Speaker Received: Grant/Research SupportOther: ­Conflict with CME Presentation: Boston Scientific

Company: ­Type of Financial Relationship: Speaker Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Company: MedtronicType of Financial Relationship: Speaker Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: ­ Received: ­Other: ­Conflict with CME Presentation: No

FLORIAN POIREAULT, France Financial disclosure: No

Lucas Policastro, United States Financial disclosure: No

Lucas Policastro, United States Financial disclosure: No

Antonio Benito Porcaro, Italy Financial disclosure: No

Antonio Benito Porcaro, Italy Financial disclosure: No

C.R. Powell, United States Financial disclosure: Yes

Company: astellasType of Financial Relationship: Other Received: Grant/Research SupportOther: investigator in RCTConflict with CME Presentation: ­

Ashish Pradhan, United Kingdom Financial disclosure: No

LISA PRODIGALIDAD, Philippines Financial disclosure: No

Page 68: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Norma Pugh, United States Financial disclosure: No

Caroline Pukall, Canada Financial disclosure: No

Bhawana Purwar, United Kingdom Financial disclosure: No

Hein Putter, Netherlands Financial disclosure: No

david quinlan, Canada Financial disclosure: Yes

Company: Cook MyositeType of Financial Relationship: Other Received: Grant/Research SupportOther: InvestigatorConflict with CME Presentation: ­

Company: AllerganType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Romich Biotechnology

Company: ­Type of Financial Relationship: Scientific Medical Advisor Received: OtherOther: Product development. No payment receivedConflict with CME Presentation: ­

Company: MerckType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: ­ Received: ­Other: ­Conflict with CME Presentation: No

Trinidad Raby, Chile Financial disclosure: No

Suneetha Rachaneni, United Kingdom Financial disclosure: No

Stephen Radley, United Kingdom Financial disclosure: Yes

Company: ePAQ Systems Ltd Type of Financial Relationship: Board Member Received: Ownership InterestOther: ­Conflict with CME Presentation: ­

Lorenz Radlinger, Switzerland Financial disclosure: No

Page 69: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

arturo radwell, Chile Financial disclosure: No

Natarajan Rajamaheswari, India Financial disclosure: No

Adam Rakowski, United Kingdom Financial disclosure: No

Rajeev Ramanah, France Financial disclosure: No

angie rantell, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: CogentixType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Allergan

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: mediplusType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Coloplast

FLAVIO RANZANI, Brazil Financial disclosure: No

Lamees Ras, South Africa Financial disclosure: Yes

Company: MedtronicType of Financial Relationship: Other Received: SalaryOther: Funded Urogynaecology FellowshipConflict with CME Presentation: ­

Karla Rebullar, Canada Financial disclosure: No

Ewa Rechberger, Poland Financial disclosure: No

Page 70: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Tomasz Rechberger, Poland Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: AllerganType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: Johnson@Johnson

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: PolherniaType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Other Received: HonorariaOther: investigator in clinical trialConflict with CME Presentation: Bayer

Shauna Regan, Canada Financial disclosure: No

aljerry rego, Brazil Financial disclosure: No

fiona reid, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Zilma Reis, Brazil Financial disclosure: No

Vladimir Revicky, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Patrick Richard, Canada Financial disclosure: No

Bernhard Richter, South Africa Financial disclosure: Yes

Page 71: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: CovidienType of Financial Relationship: Other Received: OtherOther: Sponsorship to a training course at Ircad, FranceConflict with CME Presentation: ­

Company: Legacy MedicalType of Financial Relationship: Other Received: OtherOther: Sponsorship to a training course at Ircad, FranceConflict with CME Presentation: No

Holly Richter, United States Financial disclosure: Yes

Company: PelvalonType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: PelvalonType of Financial Relationship: Other Received: Grant/Research SupportOther: Fecal incontinenceConflict with CME Presentation: UpToDate

Company: ­Type of Financial Relationship: Other Received: RoyaltyOther: Review of UpToDate articles Conflict with CME Presentation: ­

Mary Rieger, United States Financial disclosure: No

Didier Riethmuller, France Financial disclosure: Yes

Company: Sanofi Pasteur MSDType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Leonardo Righesso, Germany Financial disclosure: No

Odette Rijsdijk, Netherlands Financial disclosure: No

raheela rizvi, Pakistan Financial disclosure: No

Magali Robert, Canada Financial disclosure: Yes

Company: cook MyositeType of Financial Relationship: Other Received: Grant/Research SupportOther: investigatorConflict with CME Presentation: ­

Company: AmphoraType of Financial Relationship: Other Received: Grant/Research Support

Page 72: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Other: investigatorConflict with CME Presentation: No

Kaiser Robertson, United States Financial disclosure: No

Dudley Robinson, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Advisory Committee Member Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: PfizerType of Financial Relationship: Consultant Received: HonorariaOther: ­Conflict with CME Presentation: Allergan

Company: ­Type of Financial Relationship: Consultant Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: FerringType of Financial Relationship: Consultant Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: SEP

Company: IxaltisType of Financial Relationship: Consultant Received: HonorariaOther: ­Conflict with CME Presentation: ­

Daniela Robledo, Colombia Financial disclosure: No

Samantha Rocha, Brazil Financial disclosure: Yes

Company: Boston ScientificType of Financial Relationship: Consultant Received: Travel Grant Other: ­Conflict with CME Presentation: ­

Ian Rogers, Canada Financial disclosure: Yes

Company: Insception LifebankType of Financial Relationship: Founder Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Page 73: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Rebecca Rogers, United States Financial disclosure: Yes

Company: UptodateType of Financial Relationship: Other Received: RoyaltyOther: Write a chapter on prolapse Conflict with CME Presentation: ­

Company: American Board of Obstetrics and GynecologyType of Financial Relationship: Board Member Received: HonorariaOther: Also receive money for travelConflict with CME Presentation: International Urogynecology Journal Editor in Chief

Company: ­Type of Financial Relationship: Other Received: HonorariaOther: Also receive travel funds; Editor in ChiefConflict with CME Presentation: ­

Artur Rogowski, Poland Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

David rojano, Mexico Financial disclosure: No

Pablo Rojas, Chile Financial disclosure: No

Renee Rolston, United States Financial disclosure: No

Sabiniano Roman, United Kingdom Financial disclosure: No

Carlos Rondini, Chile Financial disclosure: No

anna rosamilia, Australia Financial disclosure: Yes

Company: AMSType of Financial Relationship: Other Received: Grant/Research SupportOther: investigator led Research grantConflict with CME Presentation: ­

Company: Boston ScientificType of Financial Relationship: Other Received: Grant/Research SupportOther: investigator led research grantand part of 522 single incision sling studyConflict with CME Presentation: astellas

Company: ­Type of Financial Relationship: Speaker Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Page 74: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Amy rosenman, United States Financial disclosure: No

Mariana Rosique, Brazil Financial disclosure: No

Suzanne Roskam, Netherlands Financial disclosure: No

Sue Ross, Canada Financial disclosure: No

Eric Rovner, United States Financial disclosure: Yes

Company: AllerganType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: AmphoraType of Financial Relationship: Scientific Medical Advisor Received: Consulting FeeOther: ­Conflict with CME Presentation: Solace

Company: ­Type of Financial Relationship: Scientific Medical Advisor Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Purim Ruanphoo, Thailand Financial disclosure: No

Emanuele Rubilotta, Italy Financial disclosure: No

Marilza Rudge, Brazil Financial disclosure: No

martin Rudnicki, Denmark Financial disclosure: No

Eider Ruiz­Mirazo, Canada Financial disclosure: No

Sandra Rule, Mexico Financial disclosure: No

Zdenek Rusavy, Czech Republic Financial disclosure: No

sophia rushd, United Kingdom Financial disclosure: No

Page 75: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

John Rutkowski, United States Financial disclosure: No

John Rutkowski, United States Financial disclosure: No

Rita Rynkevic, Portugal Financial disclosure: No

Dayana Saboia, Brazil Financial disclosure: No

Yasser Sabr, Saudi Arabia Financial disclosure: No

Anne Sammarco, United States Financial disclosure: No

May Sanaee, Canada Financial disclosure: No

Amira Sanchez, Mexico Financial disclosure: No

Peter Sand, United States Financial disclosure: Yes

Company: AllerganType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: Also recieve research grants ans speaker honorariaConflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: Also receive speaker honorariaConflict with CME Presentation: Boston Scientific

Company: ­Type of Financial Relationship: Other Received: Grant/Research SupportOther: InvestigatorConflict with CME Presentation: ­

Company: Velicept Type of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Other Received: Grant/Research SupportOther: InvestigatorConflict with CME Presentation: Cook Myosite

Company: Outpost MedicalType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Page 76: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Derrick Sanderson, United States Financial disclosure: No

Rohnn Sanderson, United States Financial disclosure: No

Carola Sandor, Argentina Financial disclosure: No

Cæsar Santiago­Arreortua, Mexico Financial disclosure: No

Giulio Santoro, Italy Financial disclosure: No

Budi Santoso, Indonesia Financial disclosure: No

Sirirat Sarit­apirak, Thailand Financial disclosure: No

alessandra sarti, Italy Financial disclosure: No

Marair Sartori, Brazil Financial disclosure: No

Jeffrey Schachar, United States Financial disclosure: No

Mark Schembri, Australia Financial disclosure: No

tobias schmidt, Germany Financial disclosure: No

Thomas Schmitz, France Financial disclosure: No

Steven Schraffordt, Netherlands Financial disclosure: Yes

Company: Intuitive SurgeryType of Financial Relationship: Other Received: Travel Grant Other: ProctorConflict with CME Presentation: ­

Steven Schraffordt Koops, Netherlands Financial disclosure: Yes

Company: Intuitive SurgeryType of Financial Relationship: Other

Page 77: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Received: Travel Grant Other: ProctorConflict with CME Presentation: ­

Letizia Schreiber, Israel Financial disclosure: No

Louise Schreiber Pedersen, Denmark Financial disclosure: No

Jane Schulz, Canada Financial disclosure: No

Margaret Scott, United States Financial disclosure: No

Katherine Sebastian, United States Financial disclosure: No

Ana Silvia Seki, Brazil Financial disclosure: No

Yosuke Seki, Japan Financial disclosure: No

YUKI SEKIGUCHI, Japan Financial disclosure: No

Allison Sellner, United States Financial disclosure: No

janaina senra, Brazil Financial disclosure: No

TAMARA SERDINSEK, Slovenia Financial disclosure: No

Babak Shadgan, Canada Financial disclosure: No

Babak Shadgan, Canada Financial disclosure: No

Nima Shah, United States Financial disclosure: No

Ala Sharaf, United Kingdom Financial disclosure: No

Anjali Sharma, United States Financial disclosure: No

Page 78: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Jai Sharma, India Financial disclosure: No

Sangeeta Sharma, India Financial disclosure: No

Fady Shehata, Canada Financial disclosure: No

Hannah Shehata, United States Financial disclosure: No

Ka Lai Shek, Australia Financial disclosure: No

yukiko shimizu, Japan Financial disclosure: No

Misa Shimoinaba, Japan Financial disclosure: No

Yu Seob Shin, Korea, Republic of Financial disclosure: No

Ryoichi Shiroki, Japan Financial disclosure: No

Oksana Shynlova, Canada Financial disclosure: No

NAVEED SIDDIQUI, Canada Financial disclosure: No

Mira Sieg, Germany Financial disclosure: No

ANTONIO AUGUSTO MOURA SILVA, Brazil Financial disclosure: No

ANTONIO AUGUSTO MOURA SILVA, Brazil Financial disclosure: No

gustavo silva, Brazil Financial disclosure: No

Agnaldo Silva­Filho, Brazil Financial disclosure: No

Page 79: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Andrea Simpson, Canada Financial disclosure: No

Nikhil Sindhwani, Belgium Financial disclosure: No

Rajeev Singh, India Financial disclosure: No

Ruchi Singh, Australia Financial disclosure: No

Kanapathippillai Sivanesan, Australia Financial disclosure: No

Amanda Skoll, Canada Financial disclosure: No

Katarzyna Skorupska, Poland Financial disclosure: Yes

Company: bayerType of Financial Relationship: Other Received: OtherOther: investigator in clinical trialConflict with CME Presentation: ­

mark slack, United Kingdom Financial disclosure: Yes

Company: Cambridge Medical RoboticsType of Financial Relationship: Board Member Received: Intellectual Property RightsOther: No conflict of interestConflict with CME Presentation: ­

cornelis slump, Netherlands Financial disclosure: No

Anthony Smith, United Kingdom Financial disclosure: No

Benjamin Smith, United States Financial disclosure: No

Kate Smith, Canada Financial disclosure: No

Noam Smorgick, Israel Financial disclosure: No

Pablo Sobarzo, Chile Financial disclosure: No

Page 80: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Aligholi Sobhani Sanjbad, Canada Financial disclosure: No

Kamil Sobocinski, Poland Financial disclosure: No

Hector Soderini, Argentina Financial disclosure: No

Francisca Solar Altamirano, Australia Financial disclosure: No

Meir Solnik, Canada Financial disclosure: Yes

Company: MedtronicType of Financial Relationship: Consultant Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: AbbvieType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: Allergan

Company: ­Type of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Eskinder Solomon, United Kingdom Financial disclosure: No

Jeong Hwan Son, Korea, Republic of Financial disclosure: No

MARIA SOTO, Chile Financial disclosure: No

Oldrich Sottner, Czech Republic Financial disclosure: No

sushma Srikrishna, United Kingdom Financial disclosure: No

Klaudia Stangel ­ W? , Poland Financial disclosure: No

Klaudia Stangel­Wojcikiewicz, Poland Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Page 81: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Marius Stanimir, Belgium Financial disclosure: No

Anny Stari, United Kingdom Financial disclosure: Yes

Company: Astellas Pharma EMEA LtdType of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Lauren Stewart, Canada Financial disclosure: Yes

Company: Broadstreet Health Economics and Outcomes ResearchType of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Erica Stockwell, United States Financial disclosure: No

Arvid Stordahl, Norway Financial disclosure: No

oscar storme, Chile Financial disclosure: No

Lynn Stothers, Canada Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Advisory Committee Member Received: HonorariaOther: ­Conflict with CME Presentation: ­

Nishamini Subramaniam, Australia Financial disclosure: No

Gennadiy Sukhikh, Russian Federation Financial disclosure: No

Mahbuba Sultana, United Kingdom Financial disclosure: No

xiuli sun, China Financial disclosure: No

xiuli sun, China Financial disclosure: No

Page 82: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Grzegorz Surkont, Poland Financial disclosure: Yes

Company: Dr Arabin companyType of Financial Relationship: Other Received: OtherOther: Financial cooperationConflict with CME Presentation: ­

Company: Astellas PharmaType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Astellas Pharma

Company: ­Type of Financial Relationship: Speaker Received: Travel Grant Other: ­Conflict with CME Presentation: ­

Kamil Svabik, Czech Republic Financial disclosure: Yes

Company: Boston ScientificType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Consultant Received: Travel Grant Other: ­Conflict with CME Presentation: No

laurie swaim, United States Financial disclosure: No

Carolyn Swenson, United States Financial disclosure: No

Shelagh Szabo, Canada Financial disclosure: No

MONIKA SZAFAROWSKA, Poland Financial disclosure: No

TOMOKO TAKAHASHI, Japan Financial disclosure: No

aki takase, Japan Financial disclosure: No

Okegawa Takatsugu, Japan Financial disclosure: No

naoko takazawa, Japan Financial disclosure: No

Page 83: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Masami Takeyama, Japan Financial disclosure: No

Alon Tal, Israel Financial disclosure: No

Ayman Tammaa, Austria Financial disclosure: Yes

Company: AMIType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Karl Tamussino, Austria Financial disclosure: No

Norie Tanaka, Japan Financial disclosure: No

Selphee Tang, Canada Financial disclosure: No

Laura Tellechea, United States Financial disclosure: No

Roderick Teo, United Kingdom Financial disclosure: No

Gans Thiagamoorthy, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Other Received: Travel Grant Other: Travel grant for meeting attendance Conflict with CME Presentation: ­

Company: EthiconType of Financial Relationship: Scientific Medical Advisor Received: Consulting FeeOther: ­Conflict with CME Presentation: No

Stephanie Thibault­Gagnon, Canada Financial disclosure: No

Dominique THIERS­BAUTRANT, France Financial disclosure: No

Nikesh Thiruchelvam, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Page 84: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: ColoplastType of Financial Relationship: Board Member Received: HonorariaOther: ­Conflict with CME Presentation: Yes

Elizabeth Thomas, Australia Financial disclosure: No

James Thomas, United Kingdom Financial disclosure: No

Hillard Timothy, United Kingdom Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Speaker Received: Travel Grant Other: ­Conflict with CME Presentation: ­

Company: ConsillientType of Financial Relationship: Advisory Committee Member Received: HonorariaOther: ­Conflict with CME Presentation: Mylan

Company: ­Type of Financial Relationship: Speaker Received: Travel Grant Other: ­Conflict with CME Presentation: ­

Company: EuropharmaType of Financial Relationship: Speaker Received: Travel Grant Other: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: ­ Received: ­Other: ­Conflict with CME Presentation: No

Douglas Tincello, United Kingdom Financial disclosure: Yes

Company: AllerganType of Financial Relationship: Speaker Received: HonorariaOther: Honorarium for speaking paid via the University's Business office Conflict with CME Presentation: ­

Wiebren Tjalma, Belgium Financial disclosure: No

Shino Tokiwa, Japan Financial disclosure: No

louise Tomlinson, New Zealand Financial disclosure: No

Page 85: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Kuwata Tomoko, Japan Financial disclosure: No

Philip Toozs­Hobson, United Kingdom Financial disclosure: Yes

Company: European Specialist PharmaType of Financial Relationship: Advisory Committee Member Received: HonorariaOther: travel assistanceConflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Pierre Fabre

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: Boston ScientificType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: Allegan

Nicolo Trabacchin, Italy Financial disclosure: No

Alexis Tran, United States Financial disclosure: No

Carlos Trujillo, Colombia Financial disclosure: No

Anna Tsviban, Israel Financial disclosure: No

Le Mai Tu, Canada Financial disclosure: No

Justin Turcotte, United States Financial disclosure: No

Friyan Turel, Australia Financial disclosure: No

Robin Turner, Australia Financial disclosure: No

Page 86: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Tanya Tyagi, Canada Financial disclosure: No

Enrique Ubertazzi, Argentina Financial disclosure: Yes

Company: PROMEDOM SA.Type of Financial Relationship: Consultant Received: Travel Grant Other: ­Conflict with CME Presentation: ­

Aiste Ugianskiene, Denmark Financial disclosure: No

Daniela Ulrich, Austria Financial disclosure: No

Wolfgang Umek, Austria Financial disclosure: No

Iva Urbankova, Belgium Financial disclosure: No

Sergio ureta, Mexico Financial disclosure: No

Maria Jose Urzua, Chile Financial disclosure: No

Ma Clarissa Uy­Patrimonio, Philippines Financial disclosure: No

Donald Vaganee, Belgium Financial disclosure: No

Alice Vale, Brazil Financial disclosure: No

Crissie van den Akker, Netherlands Financial disclosure: No

Tine van den Bos, Netherlands Financial disclosure: No

Frieda van den Noort, Netherlands Financial disclosure: Yes

Company: TomTec Type of Financial Relationship: Other Received: Grant/Research SupportOther: Inovation voucher: Half paid by the university half by the companyConflict with CME Presentation: ­

Page 87: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Frank Van der Aa, Belgium Financial disclosure: Yes

Company: ColoplastType of Financial Relationship: Other Received: HonorariaOther: proctor for Altis slingConflict with CME Presentation: ­

Company: IpsenType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Astellas

Company: ­Type of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: ­

Company: MedtronicType of Financial Relationship: Consultant Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Company: ­Type of Financial Relationship: Other Received: Grant/Research SupportOther: unrestricted grant for scientific fundConflict with CME Presentation: Allergan

Company: AstellasType of Financial Relationship: Other Received: Grant/Research SupportOther: unrestricted grant for scientific fundConflict with CME Presentation: ­

Carl van der vaart, Netherlands Financial disclosure: No

Heleen van Dongen, Netherlands Financial disclosure: No

Barbara Van Elst, Belgium Financial disclosure: No

Isabelle van Gruting, United Kingdom Financial disclosure: No

Sandra van Keulen, Belgium Financial disclosure: No

heather van Raalte, United States Financial disclosure: Yes

Company: Artann LaboratoriesType of Financial Relationship: Stock Shareholder Received: Grant/Research SupportOther: ­Conflict with CME Presentation: ­

Company: AMSType of Financial Relationship: Consultant Received: Grant/Research Support

Page 88: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Other: Consulting FeeConflict with CME Presentation: Coloplast

Company: ­Type of Financial Relationship: Consultant Received: Grant/Research SupportOther: Consulting FeeConflict with CME Presentation: ­

Company: ACellType of Financial Relationship: Consultant Received: Grant/Research SupportOther: Consulting FeeConflict with CME Presentation: ­

Company: ­Type of Financial Relationship: ­ Received: ­Other: ­Conflict with CME Presentation: Yes

Jacobus van Rensburg, South Africa Financial disclosure: Yes

Company: Earth MedicalType of Financial Relationship: Other Received: OtherOther: Donation to UniversityAccomodation FIGO October 2015Conflict with CME Presentation: ­

Company: Neo medical Type of Financial Relationship: Other Received: Travel Grant Other: Presentation data ICS June 2014Research grants: Self proposed single incision sling researchConflict with CME Presentation: Boston Scientific

Company: ­Type of Financial Relationship: Other Received: OtherOther: Sponsorship registration IUGA 2016Conflict with CME Presentation: ­

Marijn van Stralen, Netherlands Financial disclosure: No

Femke van Zanten, Netherlands Financial disclosure: No

Jakob Vange, Denmark Financial disclosure: Yes

Company: Coloplast A/SType of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Camila Vasconcelos, Brazil Financial disclosure: No

Josæ Vasconcelos Neto, Brazil Financial disclosure: No

José Ananias Vasconcelos Neto, Brazil Financial disclosure: No

Page 89: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Mayooran Veerasingham, Australia Financial disclosure: No

Nikolaus Veit­Rubin, United Kingdom Financial disclosure: No

Victor Velasco, United States Financial disclosure: No

Daniel Velez, Mexico Financial disclosure: No

monica venegas, Chile Financial disclosure: No

Alexandra Vermandel, Belgium Financial disclosure: No

Giovana Vesentini, Brazil Financial disclosure: No

Holly Vickers, United Kingdom Financial disclosure: No

SEBASTIAN VIGUERA, Chile Financial disclosure: No

Nadia Villanueva, Mexico Financial disclosure: No

Anouk Vinckier, Belgium Financial disclosure: No

Emmanuelle Vintejoux, France Financial disclosure: No

Jaromir Vlacil, Czech Republic Financial disclosure: No

Jeroen Voorham, Netherlands Financial disclosure: Yes

Company: Novuqare Pelvic Health BVType of Financial Relationship: Stock Shareholder Received: Ownership InterestOther: ­Conflict with CME Presentation: ­

Petra Voorham­ van der Zalm, Netherlands Financial disclosure: Yes

Company: NovuqareType of Financial Relationship: Scientific Medical Advisor Received: Grant/Research Support

Page 90: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Other: ­Conflict with CME Presentation: ­

Radoslaw Wach, Poland Financial disclosure: No

Parit Wachasiddhisilpa, Thailand Financial disclosure: No

Kristin Wadsworth, Canada Financial disclosure: No

Mark Wakabayashi, United States Financial disclosure: No

Annika Waldmann, Germany Financial disclosure: No

David Walker, United States Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Employee Received: SalaryOther: ­Conflict with CME Presentation: ­

Briana Walton, United States Financial disclosure: No

Yee Ki Wan, Hong Kong Financial disclosure: No

jianliu wang, China Financial disclosure: No

JIANLIU WANG, China Financial disclosure: No

JIANLIU WANG, China Financial disclosure: No

JIANLIU WANG, China Financial disclosure: No

Shiyan Wang, China Financial disclosure: No

Xiaojuan Wang, China Financial disclosure: No

Yiting Wang, China Financial disclosure: No

Page 91: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Alison Watson, United Kingdom Financial disclosure: No

Pierre Weber, France Financial disclosure: No

Alison Weidner, United States Financial disclosure: Yes

Company: GenProbeType of Financial Relationship: Other Received: Grant/Research SupportOther: spouseConflict with CME Presentation: ­

Company: GlaxoSmithKlineType of Financial Relationship: Other Received: Grant/Research SupportOther: spouseConflict with CME Presentation: Merck

Company: ­Type of Financial Relationship: Consultant Received: Consulting FeeOther: spouseConflict with CME Presentation: ­

Company: College of American PathologistsType of Financial Relationship: Consultant Received: Consulting FeeOther: spouseConflict with CME Presentation: ­

Company: ­Type of Financial Relationship: ­ Received: ­Other: ­Conflict with CME Presentation: No

Lieming wen, China Financial disclosure: No

Qi Wen, Canada Financial disclosure: No

Amanda White, United States Financial disclosure: No

Arne Wibe, Norway Financial disclosure: No

Anja Wiesner, Germany Financial disclosure: No

Scott Wildman, United Kingdom Financial disclosure: No

Harvey Winkler, United States Financial disclosure: Yes

Page 92: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Company: Boston ScientificType of Financial Relationship: Consultant Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Company: AllerganType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: No

Meg Wise, United States Financial disclosure: No

Edyta Wlazlak, Poland Financial disclosure: Yes

Company: Dr Arabin companyType of Financial Relationship: Other Received: OtherOther: financial cooperationConflict with CME Presentation: ­

Edyta Wla?lak, Poland Financial disclosure: Yes

Company: Dr ArabinType of Financial Relationship: Other Received: OtherOther: financial cooperationConflict with CME Presentation: ­

Company: AstellasType of Financial Relationship: Speaker Received: HonorariaOther: ­Conflict with CME Presentation: Yes

Wiktor Wla?lak, Poland Financial disclosure: No

Alan Wolfe, United States Financial disclosure: Yes

Company: Astellas Scientific and Medical Affairs Type of Financial Relationship: Other Received: Grant/Research SupportOther: Investigator Initiated ProjectConflict with CME Presentation: ­

Company: Kimberly Clark CorporationType of Financial Relationship: Other Received: Grant/Research SupportOther: Investigator Initiated ProjectConflict with CME Presentation: No

darcy wolfman, United States Financial disclosure: No

Ka Woon Wong, United Kingdom Financial disclosure: No

Page 93: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Vivien Wong, Australia Financial disclosure: No

andrzej wrobel, Poland Financial disclosure: No

Ling­Ying Wu, Taiwan Financial disclosure: No

Dariusz Wydra, Poland Financial disclosure: No

Bing Xie, China Financial disclosure: No

Tomonori Yamanishi, Japan Financial disclosure: Yes

Company: AsterasType of Financial Relationship: Other Received: Grant/Research SupportOther: Research grantConflict with CME Presentation: ­

Jenn­Ming Yang, Taiwan Financial disclosure: No

JU­CHUN YANG, China Financial disclosure: No

Maryna Yaskina, CanadaFinancial disclosure: No

Tajnoos Yazdany, United States Financial disclosure: Yes

Company: PfizerType of Financial Relationship: Other Received: Grant/Research SupportOther: Grant recipientConflict with CME Presentation: ­

Chen Yisong, China Financial disclosure: No

Chin Yong, Australia Financial disclosure: No

Hana Yoon, Korea, Republic of Financial disclosure: No

Kazuaki Yoshimura, Japan Financial disclosure: No

Page 94: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

yasukuni Yoshimura, Japan Financial disclosure: No

natharnia young, Australia Financial disclosure: No

CHUN HUNG YU, Hong Kong Financial disclosure: No

Sabrina Zaccaria, Netherlands Financial disclosure: No

Roman Zachoval, Czech Republic Financial disclosure: Yes

Company: AstellasType of Financial Relationship: Advisory Committee Member Received: Consulting FeeOther: ­Conflict with CME Presentation: ­

Libor Zamecnik, Czech Republic Financial disclosure: No

Rebekah Zee, Canada Financial disclosure: No

Aldene Zeno, United States Financial disclosure: No

Lili Zhang, China Financial disclosure: No

Yong Zheng, United States Financial disclosure: No

Lan Zhu, China Financial disclosure: No

Chen Zhuoran, Australia Financial disclosure: No

Alicja Zietek, Poland Financial disclosure: No

Jessica Zigman, United States Financial disclosure: No

Ariel Zilberlicht, Israel Financial disclosure: No

Page 95: Co n f lict wit h CME P re se n t a t io n · H i r o k a zu A b e, Japan F i n a n ci a l d i scl o su r e : N o Ta m e r A b o u s h w a r e b , United States F i n a n ci a l d

Elan Ziv, Israel Financial disclosure: Yes

Company: ConTIPI Medical LtdType of Financial Relationship: CEO Received: SalaryOther: Founder and ShareholderConflict with CME Presentation: ­

Company: ConTIPI LtdType of Financial Relationship: CEO Received: Ownership InterestOther: Founder and SharholderConflict with CME Presentation: Abbott Israel

Company: ­Type of Financial Relationship: Other Received: Consulting FeeOther: ConsultingConflict with CME Presentation: ­


Recommended